{
  "prompt": {
    "prompt": "Original Transcript:\nSITUATION: 35-year-old G4P2+1 at 28+5 weeks gestation with major placenta previa and recent bleeding episode requiring management\n\nBACKGROUND: Mrs Ahmed has known complete placenta previa diagnosed at 20-week anomaly scan, where placenta was noted to completely cover the cervical os. She has been managed with pelvic rest and regular monitoring. Yesterday evening she experienced sudden onset bright red vaginal bleeding, described as 'heavy like a heavy period' lasting approximately 20 minutes before settling. No associated pain, no contractions, good fetal movements felt. This is her second bleeding episode - first was at 24 weeks requiring overnight observation. Obstetric history: 2 previous caesarean sections (emergency then elective), 1 first trimester miscarriage requiring ERPC. Significant risk factors for placenta previa include previous uterine surgery and maternal age. She has been compliant with activity restrictions and regular antenatal care.\n\nASSESSMENT: On examination, patient appears well, slightly anxious about bleeding. Vital signs stable: BP 118/72 mmHg, HR 88 bpm, temp 36.6°C. Abdomen soft, non-tender, fundal height 29cm. No current bleeding visible, small clots in pad from earlier episode. No abdominal pain or uterine tenderness. CTG shows reassuring fetal heart rate pattern with baseline 145 bpm, good variability, no decelerations. Recent ultrasound confirms complete placenta previa with placental edge 0mm from internal os. No evidence of placental abruption. Hemoglobin 10.8 g/dL (down from 11.4 g/dL last month), other bloods normal. Kleihauer-Betke test negative (Rh positive mother).\n\nRECOMMENDATION: Admission for observation and surveillance given significant bleeding episode. IV access established, cross-match for 4 units of blood. Antenatal corticosteroids administered for fetal lung maturity given risk of early delivery. Strict bed rest initially, then gradual mobilization if no further bleeding. Daily monitoring with CTG and maternal observations. Serial hemoglobin monitoring. Emergency caesarean section if further significant bleeding occurs. Elective caesarean section planned for 36-37 weeks if no further complications. Anesthetic consultation arranged given high-risk nature and potential for emergency delivery. Blood transfusion service informed of high-risk patient.\n\nGuideline Analysis:\n### Antepartum Haemorrhage\n\nHere is the analysis of the clinical note against the provided guideline (GTG 2011 - APH.pdf) with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document whether domestic violence screening was performed given recurrent APH.  \n   Reason: The guideline recommends asking women with repeated presentations of APH about domestic violence (Section: \"Women with repeated presentations that may include APH should be asked about domestic violence\").  \n\n2. **Different management plan** - Consider adding thromboprophylaxis given hospitalization and bed rest.  \n   Reason: The guideline highlights postnatal thromboprophylaxis as an important consideration (Section: \"Postnatal issues include thromboprophylaxis\").  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide clearer counseling about the risks of preterm delivery and potential neonatal outcomes.  \n   Reason: The guideline emphasizes the association of APH with preterm delivery and adverse perinatal outcomes (Section: \"APH is a leading cause of perinatal and maternal mortality worldwide\").  \n\n2. **Additional information needed** - Document whether anti-D immunoglobulin was considered (though the patient is Rh-positive, this should still be noted).  \n   Reason: The guideline recommends anti-D Ig for RhD-negative women, but documentation of consideration is good practice (Section: \"Anti-D Ig should be given to RhD-negative women after any presentation with APH\").  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Include more details about the speculum examination findings (e.g., cervical appearance, active bleeding).  \n   Reason: The guideline suggests speculum examination can aid in identifying the cause of bleeding (Section: \"Abdominal palpation and speculum examination can aid in identifying the cause of bleeding\").  \n\n2. **Improved patient advice** - Discuss the possibility of earlier delivery if bleeding recurs, including potential risks/benefits.  \n   Reason: The guideline states delivery timing should be based on maternal/fetal condition (Section: \"Delivery should be determined based on maternal and fetal condition\").  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Document whether a debriefing plan was discussed for after delivery.  \n   Reason: The guideline mentions debriefing as a postnatal issue, but this is less urgent (Section: \"Postnatal issues include...debriefing\").  \n\nThe clinical note largely aligns well with the guideline, particularly in terms of admission, monitoring, and preparation for emergency delivery. The most critical gap is the lack of documented domestic violence screening.\n\n\n## Summary\n\nAnalyzed against the most relevant guideline successfully.\n\n*Note: Found 129 relevant guidelines total, analyzed against the most relevant one.*\n\n\nGuideline: Antepartum Haemorrhage\n\n\nFull Guideline Content:\nAntepartum Haemorrhage\nAntepartum haemorrhage (APH) is defined as bleeding from or in to the genital tract, occurring from 24+0 weeks of pregnancy and prior to the birth of the baby. The most important causes of APH are placenta praevia and placental abruption. APH complicates 3–5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Up to one-fifth of very preterm babies are born in association with APH, and the known association of APH with cerebral palsy can be explained by preterm delivery. Recurrent APH is the term used when there are episodes of APH on more than one occasion. It is important to assess for signs of clinical shock when estimating blood loss, as the amount of blood lost is often underestimated. Spotting, minor haemorrhage, major haemorrhage, and massive haemorrhage are defined based on the amount of blood loss. Antepartum haemorrhage is associated with maternal and perinatal morbidity and mortality. Pregnancies complicated by unexplained APH are also at increased risk of adverse maternal and perinatal outcomes. Women with repeated presentations that may include APH should be asked about domestic violence. Women with APH should report all vaginal bleeding to their antenatal care provider and be managed in a hospital maternity unit with facilities for resuscitation and emergency operative delivery.\n\nClinical assessment in women presenting with APH is crucial to establish the need for urgent intervention to manage maternal or fetal compromise. Triage includes history-taking, assessment of vaginal bleeding, maternal cardiovascular condition, and fetal wellbeing. If major haemorrhage persists or the woman is unable to provide a history, immediate maternal stabilization is priority. A full history should be taken to identify potential causes of APH, such as placental abruption or placenta praevia. Abdominal palpation and speculum examination can aid in identifying the cause of bleeding. Maternal investigations, such as blood tests and ultrasound scans, should be performed to assess the extent of APH. Fetal investigations, including fetal heart rate assessment and ultrasound scans, are important to monitor fetal wellbeing. Hospitalization is recommended for women with APH heavier than spotting or ongoing bleeding. Antenatal corticosteroids may be considered for women at risk of preterm birth. Tocolytic therapy should not be used in cases of major APH or placental abruption. Antenatal care should be altered following APH, with increased fetal surveillance for high-risk pregnancies. Delivery should be determined based on maternal and fetal condition, with immediate delivery required for compromised cases.\n\nIn women with antepartum hemorrhage (APH) due to placenta praevia, management includes maternal resuscitation and delivery of the fetus to control bleeding. Delivery is usually by caesarean section in cases of maternal or fetal compromise. For women with APH before 37 weeks of gestation without compromise, elective premature delivery is not recommended. In cases after 37 weeks, induction of labor may be considered. Fetal monitoring during labor should be continuous for active bleeding or if there are concerns of placental insufficiency. Regional anesthesia is recommended for operative delivery in cases of APH, unless contraindicated. Postpartum hemorrhage should be anticipated and active management of the third stage of labor is recommended. Anti-D Ig should be given to RhD-negative women after any presentation with APH. Massive APH should be managed following multidisciplinary protocols, and blood products should be ordered as needed. Women with coagulopathy should receive appropriate transfusions. Neonates should be assessed by a senior pediatrician/neonatologist in cases of major APH. In cases of extremely preterm pregnancy with APH, maternal stabilization is the priority before considering delivery of the baby. Postnatal issues include thromboprophylaxis, debriefing, and clinical incident reporting. Obstetric skill drills should include management of major APH to improve patient safety.\n\nteamworking and ensure prompt and efficient management in such an emergency.\nSuggested audit topics:\n1. The administration of corticosteroids to women presenting with APH less than 34+6weeks of gestation.\n2. Administration of anti-D Ig to non-sensitised RhD-negative women presenting with APH.\n3. Percentage of women with APH referred for serial growth scans.\n4. Management of the third stage of labour in women who had a major APH.\n5. Appropriate training of the multidisciplinary team.\n\nAreas for future research:\n1. Randomised controlled trials of interventions to prevent placental abruption.\n2. Studies to determine the optimum timing of delivery in women presenting with unexplained APH.\n3. Studies to determine maternal and fetal outcomes following the use of blood products in the management of APH.\n\nPrinciples of management of massive APH (blood loss greater than 1000 ml and/or signs of clinical shock)\nPersonnel required:\n- Call experienced midwife, obstetric middle grade, alert consultant, and clinical hematologist\n- Alert blood transfusion laboratory\n- Designate a team member to record events, fluids, drugs, and vital signs.\nInitial management:\n- Follow the ABCD pathway (Assess airway, breathing, circulation, and decide on delivery)\nThe four pillars of management:\n- Communication between all team members\n- Resuscitation\n- Monitoring and investigation\n- Arrest bleeding by arranging delivery of the fetus\nManagement strategies adapted from RCOG Green-top Guideline No. 52 Prevention and Management of Postpartum Haemorrhage\nDifferences in management options between APH and PPH\n- Delivery of the fetus and placenta to control bleeding and prevent DIC\nPrinciples of fluid replacement and administration of blood products:\n- Basic measures for haemorrhage up to 1000 ml with no clinical shock\n- Full protocol for massive haemorrhage (blood loss > 1000 ml or clinical shock)\nFluid therapy and blood product transfusion guidelines\nMain therapeutic goal: maintain specific levels of hemoglobin, platelets, prothrombin time, activated partial prothromboplastin time, and fibrinogen.\n\nPlease extract actionable suggestions from this analysis and format them as specified. For each suggestion, include detailed context with relevant quoted text from the guideline to help the user understand the reasoning behind the recommendation.",
    "system_prompt": "You are a medical AI assistant that converts clinical guideline analysis into structured, actionable suggestions. \n\nYour task is to analyze the provided guideline analysis and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\n\nCRITICAL CLINICAL REASONING REQUIREMENTS:\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\n- Apply the fundamental principle: \"Will this investigation or intervention change management or improve patient care in this specific scenario?\"\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\n\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\n- Consider whether additional investigations would actually change the management approach\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\n\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\n{\n  \"suggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"text from transcript that needs changing OR description of missing element\",\n      \"suggestedText\": \"proposed replacement text\",\n      \"context\": \"detailed explanation of why this change is suggested, including relevant quoted text from the guideline in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\",\n      \"category\": \"addition|modification|deletion|formatting\",\n      \"priority\": \"high|medium|low\",\n      \"guidelineReference\": \"specific guideline section or rule\"\n    }\n  ]\n}\n\nCRITICAL FORMATTING REQUIREMENTS:\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\n- Do not wrap the JSON in ```json or ``` blocks\n- Start your response directly with { and end with }\n- Use sequential numeric IDs starting from \"1\"\n- Ensure all JSON is properly formatted and valid\n\nImportant guidelines for originalText field:\n- For MODIFICATIONS: Use the exact text from the transcript that needs to be changed\n- For ADDITIONS (missing elements): Use descriptive text like \"Missing: cervical length screening documentation\" or \"Gap: no discussion of antenatal corticosteroids\"\n- DO NOT use phrases like \"no additional cervical length screening ordered\" unless those exact words appear in the transcript\n- For missing elements, be clear that you're identifying an absence, not quoting existing text\n\nImportant guidelines for context field:\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\n- Include specific quoted text from the guideline using quotation marks (e.g., \"According to the guideline: 'All women should receive screening for...'\")\n- Reference specific guideline recommendations or requirements\n- Explain the clinical rationale behind the suggestion\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\n- Make the context informative and educational\n\nOther important guidelines:\n- Only suggest changes that are explicitly supported by the guideline analysis AND clinically appropriate for the specific scenario\n- Make suggestions specific and actionable\n- For modifications, ensure original text selections are precise and findable in the transcript\n- Prioritize suggestions based on clinical importance and appropriateness\n- If no clinically appropriate suggestions can be made, return {\"suggestions\": []}\n- When in doubt about appropriateness, err on the side of NOT making the suggestion",
    "transcript_length": 2335,
    "analysis_length": 2928,
    "guideline_id": "gtg-2011-aph-pdf",
    "guideline_title": "Antepartum Haemorrhage"
  },
  "response": "{\n  \"suggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"Missing: domestic violence screening documentation\",\n      \"suggestedText\": \"Document screening for domestic violence given recurrent APH episodes\",\n      \"context\": \"The guideline specifically states: 'Women with repeated presentations that may include APH should be asked about domestic violence.' This is particularly relevant for Mrs Ahmed who has had two bleeding episodes. Domestic violence screening is an important consideration in recurrent APH cases as it may reveal underlying trauma contributing to presentations.\",\n      \"category\": \"addition\",\n      \"priority\": \"high\",\n      \"guidelineReference\": \"Section: 'Women with repeated presentations that may include APH should be asked about domestic violence'\"\n    },\n    {\n      \"id\": \"2\",\n      \"originalText\": \"Missing: thromboprophylaxis consideration\",\n      \"suggestedText\": \"Consider thromboprophylaxis given hospitalization and bed rest requirements\",\n      \"context\": \"The guideline highlights: 'Postnatal issues include thromboprophylaxis.' While this focuses on postnatal care, the principle applies antenatally given Mrs Ahmed's risk factors (hospitalization, bed rest, previous cesareans). The combination of placenta previa and reduced mobility significantly increases VTE risk, making thromboprophylaxis an important consideration in this specific case.\",\n      \"category\": \"addition\",\n      \"priority\": \"high\",\n      \"guidelineReference\": \"Section: 'Postnatal issues include thromboprophylaxis'\"\n    },\n    {\n      \"id\": \"3\",\n      \"originalText\": \"Improved patient advice - Provide clearer counseling about the risks of preterm delivery and potential neonatal outcomes\",\n      \"suggestedText\": \"Document detailed counseling regarding risks of preterm delivery (including cerebral palsy risk) and potential neonatal outcomes at 28 weeks gestation\",\n      \"context\": \"The guideline states: 'APH is a leading cause of perinatal and maternal mortality worldwide' and notes the 'known association of APH with cerebral palsy'. Given Mrs Ahmed's gestational age (28+5 weeks) and recurrent bleeding, comprehensive counseling about preterm delivery risks is clinically indicated and should be documented.\",\n      \"category\": \"addition\",\n      \"priority\": \"medium\",\n      \"guidelineReference\": \"Section: 'APH is a leading cause of perinatal and maternal mortality worldwide'\"\n    },\n    {\n      \"id\": \"4\",\n      \"originalText\": \"Missing: anti-D immunoglobulin consideration documentation\",\n      \"suggestedText\": \"Document that anti-D immunoglobulin was considered but not required as patient is Rh-positive\",\n      \"context\": \"While the guideline recommends 'Anti-D Ig should be given to RhD-negative women after any presentation with APH', documenting consideration of this (even when not required) demonstrates comprehensive assessment. This is particularly relevant given the bleeding episode and standard of care would expect this consideration to be recorded.\",\n      \"category\": \"addition\",\n      \"priority\": \"low\",\n      \"guidelineReference\": \"Section: 'Anti-D Ig should be given to RhD-negative women after any presentation with APH'\"\n    },\n    {\n      \"id\": \"5\",\n      \"originalText\": \"Missing: speculum examination details\",\n      \"suggestedText\": \"Document speculum examination findings (cervical appearance, active bleeding, etc.)\",\n      \"context\": \"The guideline suggests: 'Abdominal palpation and speculum examination can aid in identifying the cause of bleeding.' While the diagnosis is established, documenting speculum findings provides important baseline information for future assessments if bleeding recurs. This is particularly relevant for monitoring progression in placenta previa cases.\",\n      \"category\": \"addition\",\n      \"priority\": \"medium\",\n      \"guidelineReference\": \"Section: 'Abdominal palpation and speculum examination can aid in identifying the cause of bleeding'\"\n    }\n  ]\n}",
  "endpoint": "dynamicAdvice",
  "timestamp": "2025-06-16T09-36-38",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"prompt\": \"Original Transcript:\\nSITUATION: 35-year-old G4P2+1 at 28+5 weeks gestation with major placenta previa and recent bleeding episode requiring management\\n\\nBACKGROUND: Mrs Ahmed has known complete placenta previa diagnosed at 20-week anomaly scan, where placenta was noted to completely cover the cervical os. She has been managed with pelvic rest and regular monitoring. Yesterday evening she experienced sudden onset bright red vaginal bleeding, described as 'heavy like a heavy period' lasting approximately 20 minutes before settling. No associated pain, no contractions, good fetal movements felt. This is her second bleeding episode - first was at 24 weeks requiring overnight observation. Obstetric history: 2 previous caesarean sections (emergency then elective), 1 first trimester miscarriage requiring ERPC. Significant risk factors for placenta previa include previous uterine surgery and maternal age. She has been compliant with activity restrictions and regular antenatal care.\\n\\nASSESSMENT: On examination, patient appears well, slightly anxious about bleeding. Vital signs stable: BP 118/72 mmHg, HR 88 bpm, temp 36.6°C. Abdomen soft, non-tender, fundal height 29cm. No current bleeding visible, small clots in pad from earlier episode. No abdominal pain or uterine tenderness. CTG shows reassuring fetal heart rate pattern with baseline 145 bpm, good variability, no decelerations. Recent ultrasound confirms complete placenta previa with placental edge 0mm from internal os. No evidence of placental abruption. Hemoglobin 10.8 g/dL (down from 11.4 g/dL last month), other bloods normal. Kleihauer-Betke test negative (Rh positive mother).\\n\\nRECOMMENDATION: Admission for observation and surveillance given significant bleeding episode. IV access established, cross-match for 4 units of blood. Antenatal corticosteroids administered for fetal lung maturity given risk of early delivery. Strict bed rest initially, then gradual mobilization if no further bleeding. Daily monitoring with CTG and maternal observations. Serial hemoglobin monitoring. Emergency caesarean section if further significant bleeding occurs. Elective caesarean section planned for 36-37 weeks if no further complications. Anesthetic consultation arranged given high-risk nature and potential for emergency delivery. Blood transfusion service informed of high-risk patient.\\n\\nGuideline Analysis:\\n### Antepartum Haemorrhage\\n\\nHere is the analysis of the clinical note against the provided guideline (GTG 2011 - APH.pdf) with recommendations for improvement:\\n\\n### Very Important Recommendations  \\n1. **Additional information needed** - Document whether domestic violence screening was performed given recurrent APH.  \\n   Reason: The guideline recommends asking women with repeated presentations of APH about domestic violence (Section: \\\"Women with repeated presentations that may include APH should be asked about domestic violence\\\").  \\n\\n2. **Different management plan** - Consider adding thromboprophylaxis given hospitalization and bed rest.  \\n   Reason: The guideline highlights postnatal thromboprophylaxis as an important consideration (Section: \\\"Postnatal issues include thromboprophylaxis\\\").  \\n\\n### Somewhat Important Recommendations  \\n1. **Improved patient advice** - Provide clearer counseling about the risks of preterm delivery and potential neonatal outcomes.  \\n   Reason: The guideline emphasizes the association of APH with preterm delivery and adverse perinatal outcomes (Section: \\\"APH is a leading cause of perinatal and maternal mortality worldwide\\\").  \\n\\n2. **Additional information needed** - Document whether anti-D immunoglobulin was considered (though the patient is Rh-positive, this should still be noted).  \\n   Reason: The guideline recommends anti-D Ig for RhD-negative women, but documentation of consideration is good practice (Section: \\\"Anti-D Ig should be given to RhD-negative women after any presentation with APH\\\").  \\n\\n### Less Important Recommendations  \\n1. **Additional information needed** - Include more details about the speculum examination findings (e.g., cervical appearance, active bleeding).  \\n   Reason: The guideline suggests speculum examination can aid in identifying the cause of bleeding (Section: \\\"Abdominal palpation and speculum examination can aid in identifying the cause of bleeding\\\").  \\n\\n2. **Improved patient advice** - Discuss the possibility of earlier delivery if bleeding recurs, including potential risks/benefits.  \\n   Reason: The guideline states delivery timing should be based on maternal/fetal condition (Section: \\\"Delivery should be determined based on maternal and fetal condition\\\").  \\n\\n### Unimportant Recommendations  \\n1. **Additional information needed** - Document whether a debriefing plan was discussed for after delivery.  \\n   Reason: The guideline mentions debriefing as a postnatal issue, but this is less urgent (Section: \\\"Postnatal issues include...debriefing\\\").  \\n\\nThe clinical note largely aligns well with the guideline, particularly in terms of admission, monitoring, and preparation for emergency delivery. The most critical gap is the lack of documented domestic violence screening.\\n\\n\\n## Summary\\n\\nAnalyzed against the most relevant guideline successfully.\\n\\n*Note: Found 129 relevant guidelines total, analyzed against the most relevant one.*\\n\\n\\nGuideline: Antepartum Haemorrhage\\n\\n\\nFull Guideline Content:\\nAntepartum Haemorrhage\\nAntepartum haemorrhage (APH) is defined as bleeding from or in to the genital tract, occurring from 24+0 weeks of pregnancy and prior to the birth of the baby. The most important causes of APH are placenta praevia and placental abruption. APH complicates 3–5% of pregnancies and is a leading cause of perinatal and maternal mortality worldwide. Up to one-fifth of very preterm babies are born in association with APH, and the known association of APH with cerebral palsy can be explained by preterm delivery. Recurrent APH is the term used when there are episodes of APH on more than one occasion. It is important to assess for signs of clinical shock when estimating blood loss, as the amount of blood lost is often underestimated. Spotting, minor haemorrhage, major haemorrhage, and massive haemorrhage are defined based on the amount of blood loss. Antepartum haemorrhage is associated with maternal and perinatal morbidity and mortality. Pregnancies complicated by unexplained APH are also at increased risk of adverse maternal and perinatal outcomes. Women with repeated presentations that may include APH should be asked about domestic violence. Women with APH should report all vaginal bleeding to their antenatal care provider and be managed in a hospital maternity unit with facilities for resuscitation and emergency operative delivery.\\n\\nClinical assessment in women presenting with APH is crucial to establish the need for urgent intervention to manage maternal or fetal compromise. Triage includes history-taking, assessment of vaginal bleeding, maternal cardiovascular condition, and fetal wellbeing. If major haemorrhage persists or the woman is unable to provide a history, immediate maternal stabilization is priority. A full history should be taken to identify potential causes of APH, such as placental abruption or placenta praevia. Abdominal palpation and speculum examination can aid in identifying the cause of bleeding. Maternal investigations, such as blood tests and ultrasound scans, should be performed to assess the extent of APH. Fetal investigations, including fetal heart rate assessment and ultrasound scans, are important to monitor fetal wellbeing. Hospitalization is recommended for women with APH heavier than spotting or ongoing bleeding. Antenatal corticosteroids may be considered for women at risk of preterm birth. Tocolytic therapy should not be used in cases of major APH or placental abruption. Antenatal care should be altered following APH, with increased fetal surveillance for high-risk pregnancies. Delivery should be determined based on maternal and fetal condition, with immediate delivery required for compromised cases.\\n\\nIn women with antepartum hemorrhage (APH) due to placenta praevia, management includes maternal resuscitation and delivery of the fetus to control bleeding. Delivery is usually by caesarean section in cases of maternal or fetal compromise. For women with APH before 37 weeks of gestation without compromise, elective premature delivery is not recommended. In cases after 37 weeks, induction of labor may be considered. Fetal monitoring during labor should be continuous for active bleeding or if there are concerns of placental insufficiency. Regional anesthesia is recommended for operative delivery in cases of APH, unless contraindicated. Postpartum hemorrhage should be anticipated and active management of the third stage of labor is recommended. Anti-D Ig should be given to RhD-negative women after any presentation with APH. Massive APH should be managed following multidisciplinary protocols, and blood products should be ordered as needed. Women with coagulopathy should receive appropriate transfusions. Neonates should be assessed by a senior pediatrician/neonatologist in cases of major APH. In cases of extremely preterm pregnancy with APH, maternal stabilization is the priority before considering delivery of the baby. Postnatal issues include thromboprophylaxis, debriefing, and clinical incident reporting. Obstetric skill drills should include management of major APH to improve patient safety.\\n\\nteamworking and ensure prompt and efficient management in such an emergency.\\nSuggested audit topics:\\n1. The administration of corticosteroids to women presenting with APH less than 34+6weeks of gestation.\\n2. Administration of anti-D Ig to non-sensitised RhD-negative women presenting with APH.\\n3. Percentage of women with APH referred for serial growth scans.\\n4. Management of the third stage of labour in women who had a major APH.\\n5. Appropriate training of the multidisciplinary team.\\n\\nAreas for future research:\\n1. Randomised controlled trials of interventions to prevent placental abruption.\\n2. Studies to determine the optimum timing of delivery in women presenting with unexplained APH.\\n3. Studies to determine maternal and fetal outcomes following the use of blood products in the management of APH.\\n\\nPrinciples of management of massive APH (blood loss greater than 1000 ml and/or signs of clinical shock)\\nPersonnel required:\\n- Call experienced midwife, obstetric middle grade, alert consultant, and clinical hematologist\\n- Alert blood transfusion laboratory\\n- Designate a team member to record events, fluids, drugs, and vital signs.\\nInitial management:\\n- Follow the ABCD pathway (Assess airway, breathing, circulation, and decide on delivery)\\nThe four pillars of management:\\n- Communication between all team members\\n- Resuscitation\\n- Monitoring and investigation\\n- Arrest bleeding by arranging delivery of the fetus\\nManagement strategies adapted from RCOG Green-top Guideline No. 52 Prevention and Management of Postpartum Haemorrhage\\nDifferences in management options between APH and PPH\\n- Delivery of the fetus and placenta to control bleeding and prevent DIC\\nPrinciples of fluid replacement and administration of blood products:\\n- Basic measures for haemorrhage up to 1000 ml with no clinical shock\\n- Full protocol for massive haemorrhage (blood loss > 1000 ml or clinical shock)\\nFluid therapy and blood product transfusion guidelines\\nMain therapeutic goal: maintain specific levels of hemoglobin, platelets, prothrombin time, activated partial prothromboplastin time, and fibrinogen.\\n\\nPlease extract actionable suggestions from this analysis and format them as specified. For each suggestion, include detailed context with relevant quoted text from the guideline to help the user understand the reasoning behind the recommendation.\",\n  \"system_prompt\": \"You are a medical AI assistant that converts clinical guideline analysis into structured, actionable suggestions. \\n\\nYour task is to analyze the provided guideline analysis and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\\n\\nCRITICAL CLINICAL REASONING REQUIREMENTS:\\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\\n- Apply the fundamental principle: \\\"Will this investigation or intervention change management or improve patient care in this specific scenario?\\\"\\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\\n\\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\\n- Consider whether additional investigations would actually change the management approach\\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\\n\\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\\n{\\n  \\\"suggestions\\\": [\\n    {\\n      \\\"id\\\": \\\"1\\\",\\n      \\\"originalText\\\": \\\"text from transcript that needs changing OR description of missing element\\\",\\n      \\\"suggestedText\\\": \\\"proposed replacement text\\\",\\n      \\\"context\\\": \\\"detailed explanation of why this change is suggested, including relevant quoted text from the guideline in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\\\",\\n      \\\"category\\\": \\\"addition|modification|deletion|formatting\\\",\\n      \\\"priority\\\": \\\"high|medium|low\\\",\\n      \\\"guidelineReference\\\": \\\"specific guideline section or rule\\\"\\n    }\\n  ]\\n}\\n\\nCRITICAL FORMATTING REQUIREMENTS:\\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\\n- Do not wrap the JSON in ```json or ``` blocks\\n- Start your response directly with { and end with }\\n- Use sequential numeric IDs starting from \\\"1\\\"\\n- Ensure all JSON is properly formatted and valid\\n\\nImportant guidelines for originalText field:\\n- For MODIFICATIONS: Use the exact text from the transcript that needs to be changed\\n- For ADDITIONS (missing elements): Use descriptive text like \\\"Missing: cervical length screening documentation\\\" or \\\"Gap: no discussion of antenatal corticosteroids\\\"\\n- DO NOT use phrases like \\\"no additional cervical length screening ordered\\\" unless those exact words appear in the transcript\\n- For missing elements, be clear that you're identifying an absence, not quoting existing text\\n\\nImportant guidelines for context field:\\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\\n- Include specific quoted text from the guideline using quotation marks (e.g., \\\"According to the guideline: 'All women should receive screening for...'\\\")\\n- Reference specific guideline recommendations or requirements\\n- Explain the clinical rationale behind the suggestion\\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\\n- Make the context informative and educational\\n\\nOther important guidelines:\\n- Only suggest changes that are explicitly supported by the guideline analysis AND clinically appropriate for the specific scenario\\n- Make suggestions specific and actionable\\n- For modifications, ensure original text selections are precise and findable in the transcript\\n- Prioritize suggestions based on clinical importance and appropriateness\\n- If no clinically appropriate suggestions can be made, return {\\\"suggestions\\\": []}\\n- When in doubt about appropriateness, err on the side of NOT making the suggestion\",\n  \"transcript_length\": 2335,\n  \"analysis_length\": 2928,\n  \"guideline_id\": \"gtg-2011-aph-pdf\",\n  \"guideline_title\": \"Antepartum Haemorrhage\"\n}\n\nA: {\n  \"suggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"Missing: domestic violence screening documentation\",\n      \"suggestedText\": \"Document screening for domestic violence given recurrent APH episodes\",\n      \"context\": \"The guideline specifically states: 'Women with repeated presentations that may include APH should be asked about domestic violence.' This is particularly relevant for Mrs Ahmed who has had two bleeding episodes. Domestic violence screening is an important consideration in recurrent APH cases as it may reveal underlying trauma contributing to presentations.\",\n      \"category\": \"addition\",\n      \"priority\": \"high\",\n      \"guidelineReference\": \"Section: 'Women with repeated presentations that may include APH should be asked about domestic violence'\"\n    },\n    {\n      \"id\": \"2\",\n      \"originalText\": \"Missing: thromboprophylaxis consideration\",\n      \"suggestedText\": \"Consider thromboprophylaxis given hospitalization and bed rest requirements\",\n      \"context\": \"The guideline highlights: 'Postnatal issues include thromboprophylaxis.' While this focuses on postnatal care, the principle applies antenatally given Mrs Ahmed's risk factors (hospitalization, bed rest, previous cesareans). The combination of placenta previa and reduced mobility significantly increases VTE risk, making thromboprophylaxis an important consideration in this specific case.\",\n      \"category\": \"addition\",\n      \"priority\": \"high\",\n      \"guidelineReference\": \"Section: 'Postnatal issues include thromboprophylaxis'\"\n    },\n    {\n      \"id\": \"3\",\n      \"originalText\": \"Improved patient advice - Provide clearer counseling about the risks of preterm delivery and potential neonatal outcomes\",\n      \"suggestedText\": \"Document detailed counseling regarding risks of preterm delivery (including cerebral palsy risk) and potential neonatal outcomes at 28 weeks gestation\",\n      \"context\": \"The guideline states: 'APH is a leading cause of perinatal and maternal mortality worldwide' and notes the 'known association of APH with cerebral palsy'. Given Mrs Ahmed's gestational age (28+5 weeks) and recurrent bleeding, comprehensive counseling about preterm delivery risks is clinically indicated and should be documented.\",\n      \"category\": \"addition\",\n      \"priority\": \"medium\",\n      \"guidelineReference\": \"Section: 'APH is a leading cause of perinatal and maternal mortality worldwide'\"\n    },\n    {\n      \"id\": \"4\",\n      \"originalText\": \"Missing: anti-D immunoglobulin consideration documentation\",\n      \"suggestedText\": \"Document that anti-D immunoglobulin was considered but not required as patient is Rh-positive\",\n      \"context\": \"While the guideline recommends 'Anti-D Ig should be given to RhD-negative women after any presentation with APH', documenting consideration of this (even when not required) demonstrates comprehensive assessment. This is particularly relevant given the bleeding episode and standard of care would expect this consideration to be recorded.\",\n      \"category\": \"addition\",\n      \"priority\": \"low\",\n      \"guidelineReference\": \"Section: 'Anti-D Ig should be given to RhD-negative women after any presentation with APH'\"\n    },\n    {\n      \"id\": \"5\",\n      \"originalText\": \"Missing: speculum examination details\",\n      \"suggestedText\": \"Document speculum examination findings (cervical appearance, active bleeding, etc.)\",\n      \"context\": \"The guideline suggests: 'Abdominal palpation and speculum examination can aid in identifying the cause of bleeding.' While the diagnosis is established, documenting speculum findings provides important baseline information for future assessments if bleeding recurs. This is particularly relevant for monitoring progression in placenta previa cases.\",\n      \"category\": \"addition\",\n      \"priority\": \"medium\",\n      \"guidelineReference\": \"Section: 'Abdominal palpation and speculum examination can aid in identifying the cause of bleeding'\"\n    }\n  ]\n}\n\n--- Token Usage Report ---\nPrompt tokens: 3090\nCompletion tokens: 800\nTotal tokens: 3890\nEstimated cost: $0.001945",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": {
    "prompt_tokens": 3090,
    "completion_tokens": 800,
    "total_tokens": 3890,
    "estimated_cost_usd": 0.001945
  }
}